Trials / Completed
CompletedNCT04750785
A Study to Assess Choroideremia (CHM) Health Outcomes
Choroideremia Health Outcomes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 46 (actual)
- Sponsor
- Biogen · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objectives of this study are to describe disease progression and severity by age in participants with CHM, to assess health-related quality-of-life, resource utilization and work productivity, and to assess quality-of-life, work productivity, and impact on daily activities in caregivers of participants with CHM at different stages of disease progression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | Administered as specified in the treatment arm. |
Timeline
- Start date
- 2020-12-15
- Primary completion
- 2021-09-27
- Completion
- 2021-09-27
- First posted
- 2021-02-11
- Last updated
- 2021-10-14
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04750785. Inclusion in this directory is not an endorsement.